Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$763K Buy
+1,810
New +$721K 0.06% 175
2026
Q2
– Sell
-1,435
Closed -$505K – 483
2026
Q1
$505K Sell
1,435
-10
-0.7% -$3.56K 0.04% 247
2025
Q4
$473K Buy
1,445
+73
+5% +$23.2K 0.04% 242
2025
Q3
$387K Buy
+1,372
New +$398K 0.03% 299
2025
Q2
– Sell
-1,318
Closed -$411K – 404
2025
Q1
$411K Sell
1,318
-897
-40% -$265K 0.04% 261
2024
Q4
$577K Buy
2,215
+32
+1% +$9.49K 0.04% 263
2024
Q3
$703K Sell
2,183
-52
-2% -$17K 0.05% 218
2024
Q2
$698K Sell
2,235
-19
-0.8% -$5.58K 0.06% 206
2024
Q1
$641K Sell
2,254
-1,431
-39% -$419K 0.05% 239
2023
Q4
$1.06M Buy
+3,685
New +$1M 0.09% 125

Other funds holding AMGN

Trust Point's AMGN Position: Q3 2026 in Review

Trust Point opened a new position in Amgen (AMGN) in Q3 2026: 1,810 shares worth $763K. The stake represents 0.06% of the portfolio and ranks #175 among its holdings. This is a return to the name: Trust Point previously reported a position in AMGN as recently as Q1 2026.

Trust Point first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.06M in Q4 2023. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Trust Point held 1,810 shares of Amgen worth $763K as of Q3 2026.
  • Amgen was a new Trust Point position in Q3 2026.
  • Amgen made up 0.06% of Trust Point's portfolio in Q3 2026, its #175 holding.
  • Trust Point first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Trust Point's Amgen position peaked at $1.06M in Q4 2023.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.